enVVeno Medical Corporation (FRA:5HJ)

Market Cap	6.26M
Revenue (ttm)	n/a
Net Income (ttm)	-18.72M
Shares Out	n/a
EPS (ttm)	-0.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	95
Open	0.2660
Previous Close	0.2760
Day's Range	0.2660 - 0.2660
52-Week Range	0.2560 - 4.4800
Beta	n/a
RSI	43.75
Earnings Date	Feb 27, 2026

About enVVeno Medical

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company’s lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based repla...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1999
• Employees: 37
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5HJ

Financial Performance

Financial numbers in USD